Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline and Behavioral Activation for Smoking Cessation in Depressed Smokers
NCT02378714Phase 4Completed
- Sponsor
- Northwestern University
- Start
- Jul 2015
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, sponsored by Northwestern University. Started Jul 2015; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT02378714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378714.